☆ 4.6 Editorial Material

COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2022)

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials

Remo Panaccione et al.

Summary: In patients with UC, CK elevations with tofacitinib appeared reversible and not associated with clinically significant AEs. The findings in UC were consistent with tofacitinib use in other inflammatory diseases.

DIGESTIVE DISEASES AND SCIENCES (2021)

添加到收藏夹

Letter Rheumatology

Symptomatic elevation creatine kinase following treatment of rheumatoid arthritis with baricitinib

Pamela Anjara et al.

CLINICAL RHEUMATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Acute steroid myopathy: a highly overlooked entity

M. Haran et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2018)

添加到收藏夹

COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation

相关参考文献

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials

Symptomatic elevation creatine kinase following treatment of rheumatoid arthritis with baricitinib

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Acute steroid myopathy: a highly overlooked entity

导出引文

分享论文